MARKET REPORT: Smith & Nephew slashes full-year sales guidance as it is rocked by slowdown in China
By Jon Hopkins Updated: 10:01 EDT, 1 November 2024 Investors in Smith & Nephew were knee-capped after the orthopaedic firm slashed its full-year sales guidance on weaker-than-expected trading in China. The FTSE 100-listed firm now anticipates full-year …